Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiphospholipid (aPL)-Positive”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Ended earlyNCT02128269
What this trial is testing

Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid (aPL)-Positive
Alexion Pharmaceuticals, Inc. 9
Post-approval studies (Phase 4)Looking for participantsNCT06722586
What this trial is testing

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

Who this might be right for
Antiphospholipid (aPL)-PositiveThrombocytopaenia
Peking University First Hospital 84
Large-scale testing (Phase 3)Ended earlyNCT01784523
What this trial is testing

Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients

Who this might be right for
Antiphospholipid Syndrome
Hospital for Special Surgery, New York 11
Not applicableStudy completedNCT01475149
What this trial is testing

Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)

Who this might be right for
Antiphospholipid SyndromeThrombophilia Due to Antiphospholipid AntibodySystemic Lupus Erythematosus
Hospital for Special Surgery, New York 33